| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.06. | Incyte Agrees to Acquire Vega Therapeutics for $1.25B | ||
| 05.06. | Sanofi Inks Five-Year Pact to License Owkin's AI Scientist K Pro for Next-Gen Biopharma Agents | ||
| 05.06. | WuXi Biologics Tops Out Modular Drug Product Facility in Singapore | ||
| 05.06. | Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines | ||
| 04.06. | Haga Bioscience Closes $2.3M Funding Round to Commercialize Spatial Biology Tech | ||
| 04.06. | Massive Bio, Optellum Partner on Early Detection, Clinical Trial Access for Lung Cancer | ||
| 04.06. | Travere Therapeutics, Everest Medicines Partner to Advance Civorebrutinib | ||
| 04.06. | Lonza, Stipple Bio Sign ADC Licensing Deal | ||
| 04.06. | Pfizer to Leverage Chai Discovery's AI Platform | ||
| 04.06. | Thermo Fisher Introduces M Series Centrifuges | ||
| 04.06. | Natera, CytoDyn Partner in Colorectal Cancer Study | ||
| 04.06. | Veranova Appoints Dr. Bob Huang as VP & GM of West Deptford, NJ Facility | ||
| 04.06. | SCHOTT Pharma Expands Vial Production in Lebanon, PA | ||
| 03.06. | Ashland Life Sciences Strengthens Presence in Asia Pacific | ||
| 03.06. | Cellares, TScan Partner to Automate Manufacture of TCR-T Candidate | ||
| 03.06. | Lonza Enhances Biologics Preclinical Development Offering | ||
| 03.06. | Lifecore Biomedical Signs Tech Transfer Agreement for Ophthalmic | ||
| 02.06. | West Appoints Michel Lagarde a President and CEO | ||
| 02.06. | Dow, Univar Solutions Sign Agreement to Distribute Low-Carbon Products | ||
| 02.06. | Aragen to Manufacture Renaissance Pharma's Fast Track mAb | ||
| 02.06. | Evotec Appoints Rui Wang as EVP, Head of Global In Silico and AI | ||
| 01.06. | Intravacc, Primrose Bio Renew Partnership Enhancing Conjugate Vaccine Development | ||
| 01.06. | T-CURX Acquires Pantherna Therapeutics to Boost Clinical Validation of In-Vivo CAR-T Therapies | ||
| 01.06. | IL Group Introduces SMCL Series RC-506E Single Minute Changeover Labeler | ||
| 01.06. | Servier Agrees to Acquire Muscular Dystrophy Business of Edgewise Therapeutics |